Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (SOC) and a BRCA mutation (BRCAm).
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jonathan A. Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon J. S. Rustin, Clare L. Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra, Daniela Matei, Anitra Fielding, Euan Macpherson, Brian Dougherty, Juliane M. Jürgensmeier, Maria Orr, Ursula Matulonis
Institutions: University College London, Kliniken Essen-Mitte, Edinburgh Cancer Research, Prince of Wales Hospital, Universitair Ziekenhuis Leuven, Mount Vernon Hospital, The Royal Melbourne Hospital, Evangelisches Krankenhaus Düsseldorf, Tel Aviv University, Sheba Medical Center, Tel Aviv Sourasky Medical Center, Indiana University School of Medicine, AstraZeneca (United Kingdom), AstraZeneca (United States), Dana-Farber Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2257499491